Australian Nuclear Science and Technology Organisation

ITRI Holds Envisioning a Better Future International Forum Featuring Global Industry Giants

Retrieved on: 
Tuesday, September 12, 2023

TAIPEI, Sept. 12, 2023 /PRNewswire/ -- As a part of its 50th anniversary celebration, ITRI hosted the International Forum Envisioning a Better Future on September 12 to explore Taiwan's forthcoming industry opportunities toward 2035.

Key Points: 
  • TAIPEI, Sept. 12, 2023 /PRNewswire/ -- As a part of its 50th anniversary celebration, ITRI hosted the International Forum Envisioning a Better Future on September 12 to explore Taiwan's forthcoming industry opportunities toward 2035.
  • The event featured participation from industry giants such as Applied Materials, Corning Incorporated, Merck, Oxford Instruments, Mitsubishi Electric, and AVL List GmbH.
  • Premier Chen Chien-jen attended the opening ceremony and acknowledged ITRI's pivotal role in empowering Taiwan's global competitiveness.
  • With representatives from the US, UK, Japan, and Europe, alongside ITRI's international partners at the forum, Lee trusted that strengthening Taiwan's global ties could ensure a reliable global supply chain.

The Kimba nuclear waste plan bites the dust. Here's what went wrong and how to do better next time

Retrieved on: 
Friday, August 11, 2023

The federal government has scrapped plans to build the nation’s first radioactive waste storage facility on farmland near Kimba in South Australia.

Key Points: 
  • The federal government has scrapped plans to build the nation’s first radioactive waste storage facility on farmland near Kimba in South Australia.
  • That’s because the “decide and defend” model, where a government decides to put radioactive waste somewhere and then attempts to defend it against the community, hasn’t worked anywhere.
  • Those countries still don’t have any process for long-term management of radioactive waste.
  • The only way to manage our radioactive waste is to engage the community from the start.

Stacking the deck

    • The traditional owners had not been consulted – in fact they were specifically excluded from the consultation process.
    • On Thursday morning, Federal Resources Minister Madeleine King told the House of Representatives she would not challenge the Federal Court decision.
    • King noted the amount of radioactive waste will keep growing, and said her department has begun work on alternative proposals.

Consulting traditional owners is crucial

    • If buried under a few metres of earth, the radiation reaching the surface is not much above normal background levels.
    • Anywhere we want to store radioactive waste in Australia is the traditional land of a group of Indigenous people.
    • Read more:
      There's a long and devastating history behind the proposal for a nuclear waste dump in South Australia

What should happen next?

    • The idea of shifting intermediate-level waste from Lucas Heights to another temporary store 1,700km away is particularly silly.
    • There’s no obvious reason it would have been better in a temporary store at Kimba than in the current temporary store of Lucas Heights.
    • Read more:
      Australia hasn't figured out low-level nuclear waste storage yet – let alone high-level waste from submarines

Looking ahead

    • But they also held out an olive branch to the federal government, recognising the waste problem hasn’t gone away.
    • ACF looks forward to constructive dialogue with the Albanese government to help develop a new and responsible approach to radioactive waste management in Australia.

American Lithium to Fast-Track Completion of Pre-Feasibility Study for Falchani

Retrieved on: 
Monday, March 6, 2023

Higher pricing is even more applicable to Falchani given the potential to precipitate battery grade lithium carbonate through its flow sheet.

Key Points: 
  • Higher pricing is even more applicable to Falchani given the potential to precipitate battery grade lithium carbonate through its flow sheet.
  • Falchani is a unique, large-scale lithium deposit on which a lot of exploration and development work has already been done.
  • American Lithium is actively engaged in the development of large-scale lithium projects within mining-friendly jurisdictions throughout the Americas.
  • American Lithium has no assurance that the outcome of these appeals will be in the Company’s favour.

Rio Tinto expresses its gratitude to search crews for locating missing capsule

Retrieved on: 
Wednesday, February 1, 2023

Rio Tinto expresses its gratitude to the Western Australia’s Department of Fire and Emergency Services for coordinating the successful search effort to locate a missing capsule lost while in transit from the company’s Gudai-Darri iron ore mine in the Pilbara, Western Australia.

Key Points: 
  • Rio Tinto expresses its gratitude to the Western Australia’s Department of Fire and Emergency Services for coordinating the successful search effort to locate a missing capsule lost while in transit from the company’s Gudai-Darri iron ore mine in the Pilbara, Western Australia.
  • Rio Tinto would also like to thank the specialist search crews from the Australian Defence Force, the Australian Radiation Protection and Nuclear Safety Agency and the Australian Nuclear Science and Technology Organisation, as well as all other support agencies, for their crucial role in the search and recovery efforts.
  • Rio Tinto Iron Ore Chief Executive Simon Trott said, “We are incredibly grateful for the hard work of everyone involved in finding the missing capsule.
  • “While the recovery of the capsule is a great testament to the skill and tenacity of the search team, the fact is it should never have been lost in the first place.

Proactive news headlines including QMines Ltd, OzAurum Resources, Narryer Metals and Green Technology Metals

Retrieved on: 
Tuesday, November 22, 2022

Click here

Key Points: 
  • Click here
    Green Technology Metals Ltd (ASX:GT1), a Canadian-focused multi-asset lithium business, has fielded further high-grade lithium assay results from its 100%-owned Root Project, 200 kilometres west of its flagship Seymour Project in Ontario, Canada.
  • Click here
    Proactive is a unique tech-enabled platform providing companies globally with a comprehensive investor engagement solution across their business lifecycle.
  • Proactive has produced over 300,000 articles and 20,000 executive interviews since it was established in 2006.
  • For more information on how Proactive can help you make a difference, email us at [email protected]

AdvanCell Closes A$18M Series B Funding Led by Morningside

Retrieved on: 
Wednesday, August 24, 2022

AdvanCell, an Australian radiopharmaceutical company with a platform technology for a revolutionary cancer treatment called Targeted Alpha Therapy, announced today the closing of an A$18 million Series B financing round led by Morningside.

Key Points: 
  • AdvanCell, an Australian radiopharmaceutical company with a platform technology for a revolutionary cancer treatment called Targeted Alpha Therapy, announced today the closing of an A$18 million Series B financing round led by Morningside.
  • AdvanCell believes this precise and powerful treatment will rapidly become a leading pillar of cancer treatment, providing treatments for diseases for which there are currently no effective options.
  • AdvanCell has a world-class team and is honoured to be advised by an outstanding Board of Directors and Scientific Advisory Board.
  • For more information visit www.advancell.com.au
    Founded in 1986 by the Chan family, Morningside is a technology and life science venture investment firm.

Proactive news headlines including Arafura Resources, Hawsons Iron, Duke Exploration and Aeris Resources

Retrieved on: 
Thursday, May 19, 2022

Click here

Key Points: 
  • Click here
    Aeris Resources Ltd (ASX:AIS) has completed the retail component of its fully underwritten one-for-4.22 pro-rata accelerated non-renounceable entitlement offer of new shares, announced on April 28.
  • Click here
    SensOre Ltd (ASX:S3N) has wound up a drilling program at Eaglehawk gold target within the Tea Well joint venture (JV) project near Meekatharra in Western Australia.
  • Proactive has produced over 300,000 articles and 20,000 executive interviews since it was established in 2006.
  • For more information on how Proactive can help you make a difference, email us at [email protected]

Highest Uranium Extraction Combined with Lowest Acid Consumption Achieved In Leach Testing at Macusani

Retrieved on: 
Wednesday, February 16, 2022

These results are from work carried out on uranium mineralization from five of the Companys uranium deposits on the Macusani Uranium Project (Macusani) in southeastern Peru and confirm excellent extraction, low acid consumption and short leach cycle times.

Key Points: 
  • These results are from work carried out on uranium mineralization from five of the Companys uranium deposits on the Macusani Uranium Project (Macusani) in southeastern Peru and confirm excellent extraction, low acid consumption and short leach cycle times.
  • 91.0 to 98.0% Uranium extraction using weak sulfuric acid at ambient temperatures;
    97.0 to 99.7% Uranium extraction using sulfuric acid at elevated temperatures (60-95C) and a variety of acid concentrations;
    Results demonstrate the ability to extract even higher levels of uranium than previously demonstrated, with lower acid consumption.
  • These recent results confirm the outstanding leach characteristics of Macusani mineralization.
  • The high recoveries, low acid consumption and short leach cycles combined with previously announced positive gravity pre-concentration results should result in additional improvements to the already robust economics for this globally significant uranium project.

Telix and SHINE partner for Lutetium-177 Supply

Retrieved on: 
Thursday, February 10, 2022

MELBOURNE, Australia and INDIANAPOLIS, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces a new global clinical supply agreement with Wisconsin-based SHINE Technologies, LLC (SHINE) for highly pure no-carrier-added (n.c.a.)

Key Points: 
  • MELBOURNE, Australia and INDIANAPOLIS, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces a new global clinical supply agreement with Wisconsin-based SHINE Technologies, LLC (SHINE) for highly pure no-carrier-added (n.c.a.)
  • SHINE will immediately commence supply of n.c.a.
  • Telix is a biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic products using Molecularly Targeted Radiation (MTR).
  • Its global supplier network includes a commercial supply agreement with ITM Isotope Technologies Munich SE (ITM), and clinical supply agreements with the Australian Nuclear Science and Technology Organisation (ANSTO), Eczacba-Monrol (Monrol), Eckert & Ziegler Strahlen- und Medizintechnik AG (EZAG) and SHINE Technologies.

Telix Expands Lutetium-177 Network with Eckert & Ziegler Clinical Supply Agreement

Retrieved on: 
Tuesday, February 8, 2022

MELBOURNE and LIEGE, Belgium, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces a global clinical supply agreement with Berlin-based Eckert & Ziegler Strahlen- und Medizintechnik AG (EZAG) for highly pure no-carrier-added (n.c.a.)

Key Points: 
  • MELBOURNE and LIEGE, Belgium, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces a global clinical supply agreement with Berlin-based Eckert & Ziegler Strahlen- und Medizintechnik AG (EZAG) for highly pure no-carrier-added (n.c.a.)
  • This agreement further enhances Telixs existing 177Lu supplier network, which includes a commercial supply agreement with ITM Isotope Technologies Munich SE, and clinical supply agreements with the Australian Nuclear Science and Technology Organisation (ANSTO), and Eczacba-Monrol (Monrol).
  • As Telix advances its late-stage clinical trials using the medical radioisotope 177Lu, it is building a global supplier network with proximity to major international markets, capable of consistently delivering high-quality, no-carrier-added 177Lu to patients.
  • Each of the partners in Telixs carefully selected 177Lu network deliver unique operating and geographic characteristics, enabling truly global delivery of product for clinical studies and eventually commercial use.